Identification of antigen selection in the human IgE response by analysis of somatic point mutations
Identification of antigen selection in the human IgE response by analysis of somatic point mutations
批准号:
nhmrc : 455440
负责人:
A/Pr Andrew Collins
金额:
$17.13万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Allergic disease affects over 25% of the Australian community. It is responsible for significant sickness and death, particularly amongst children, and its incidence is on the increase. The reasons for this, and the underlying causes of allergic disease, remain unclear. Allergic disease results from the actions of molecules called IgE antibodies, which are also associated with parasitic infection. Even in these conditions, where IgE concentrations are raised in the blood, the concentrations are too low to allow their direct study. We have recently applied molecular biological techniques to study the genes that encode IgE antibodies. Our work suggests that the IgE response can sometimes develop in a different way to that of other antibodies (eg IgG). On the other hand, laboratory (in vitro) studies over many years support the possibility that IgE and IgG develop in parallel. In this study, we wish to identify circumstances in which IgG-like IgE antibodies develop. We therefore wish to study patients with different kinds of allergic disease, and patients with other conditions that are associated with IgE production. We therefore wish to study patients who have infections with parasitic worms. We deduce the processes that give rise to IgE antibodies by analysing patterns of mutations that accumulate in antibody genes during an immune response. Over recent years, we have developed new approaches to the analysis of such mutations, and this project also seeks to further develop our mutation analysis. This more powerful analysis will be applied to the study of mutations in the IgE genes seen in different patient groups, and should allow us to quantify the proportion of IgE antibodies that develop in each way. A better understanding of the relative contributions of the two pathways to IgE, in different conditions, will transform our understanding of the IgE response, and open up new avenues for the investigation of the causes and treatment of allergic disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunoglobulin germline genes, BCR repertoire development and disease susceptibility. An investigation of haplotypic variation between individuals
-
批准号:nhmrc : 1027926
-
项目类别:Project Grants
-
资助金额:$34.66万
-
财政年份:2012
-
负责人:A/Pr Andrew Collins
-
依托单位:
B-1 B cells as a source of polyreactive IgE antibodies, in allergic individuals
-
批准号:nhmrc : 209590
-
项目类别:NHMRC Project Grants
-
资助金额:$22.09万
-
财政年份:2002
-
负责人:A/Pr Andrew Collins
-
依托单位:
The role of the hepatic mast cell in IgE mediated gastrointestinal inflammation
-
批准号:nhmrc : 980249
-
项目类别:NHMRC Project Grants
-
资助金额:$11.22万
-
财政年份:1998
-
负责人:A/Pr Andrew Collins
-
依托单位:
国内基金
海外基金
登录
查看更多内容
COSMC/Tn antigen/mTOR 轴调控胃癌细胞转移的分子机制
研究
-
批准号:2024JJ9400
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:赵娟霞
-
依托单位:
T细胞识别的鳞状细胞癌1型抗原增强干扰素-α抗丙型肝炎病毒作用的研究
-
批准号:81170386
-
项目类别:面上项目
-
资助金额:45.0万元
-
批准年份:2011
-
负责人:赵鸿
-
依托单位:
新的膀胱癌特异基因UCA1在膀胱癌高表达的分子机理
-
批准号:30801325
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2008
-
负责人:张争
-
依托单位:
基于短寿蛋白肿瘤疫苗诱导的抗瘤作用及其机制的研究
-
批准号:30771999
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2007
-
负责人:王立新
-
依托单位:
Shp2 在polyomavirus middle T antigen(mT)诱发肿瘤过程中的作用
-
批准号:30700392
-
项目类别:青年科学基金项目
-
资助金额:15.0万元
-
批准年份:2007
-
负责人:杨瑛
-
依托单位:
以Ag43为新型载体和佐剂的重组多价亚单位疫苗抗疟机理研究
-
批准号:30560160
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2005
-
负责人:谭光宏
-
依托单位:
Ag43/Fcε3嵌合细菌表面抗原蛋白疫苗抗I型变态反应研究
-
批准号:30460050
-
项目类别:地区科学基金项目
-
资助金额:19.0万元
-
批准年份:2004
-
负责人:谭光宏
-
依托单位: